Catecholamine-secreting extra-adrenal pelvic ganglioneuroma in a child presenting with diaphoresis: A case report and review of literature  by Zaghal, Ahmad et al.
Contents lists available at ScienceDirect
J Ped Surg Case Reports 2 (2014) 373e376Journal of Pediatric Surgery CASE REPORTS
journal homepage: www.jpscasereports .comCatecholamine-secreting extra-adrenal pelvic ganglioneuroma in a
child presenting with diaphoresis: A case report and review of
literatureq
Ahmad Zaghal, Graeme Pitcher, Sydney Rooney, Stacy Hitt, Patricia Kirby,
Joel Shilyansky*
University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa city, IA 52242, USAa r t i c l e i n f o
Article history:
Received 27 June 2014
Received in revised form
28 July 2014
Accepted 29 July 2014
Key words:
Ganglioneuroma
Diaphoresis
Functional adrenergic tumorq This is an open access article under the CC
creativecommons.org/licenses/by-nc-nd/3.0/).
* Corresponding author. Tel.: þ1 319 356 1766.
E-mail address: joel-shilyansky@uiowa.edu (J. Shily
2213-5766/$ e see front matter  2014 The Authors.
http://dx.doi.org/10.1016/j.epsc.2014.07.012a b s t r a c t
Diaphoresis is an uncommon presenting symptom in children. We present a 4 year old boy, with a
history of increased sweating of 2 years duration. Review of systems was negative for diarrhea, ﬂushing,
or abdominal pain. On exam, the child had normal blood pressure and heart rate. An abdominal mass
could not be appreciated. Laboratory studies were signiﬁcant for modestly elevated serum, and urinary
dopamine and norepinephrine levels. Computerized tomography scan showed a 31  39  51 mm pelvic
mass. The patient underwent laparoscopic resection of the mass. After resection, catecholamine levels
normalized, and sweating stopped. Pathologic evaluation of the surgical specimen revealed a maturing
ganglioneuroma (GN). Health-care providers might easily overlook excessive sweating in a child, which
can be a presenting symptom of catecholamine-secreting tumors.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Sweating, in normal physiologic conditions, is mediated both by
cholinergic and adrenergic stimulation. Excessive sweating, or
diaphoresis, may be caused by the beta-adrenergic effects of
circulating ectopic catecholamines, produced by functional tumors,
of which pheochromocytoma and paraganglioma are the most
common. Diaphoresis as a clinical indicator of an underlying dis-
ease has been infrequently reported in pediatric age group, espe-
cially the very young, and might be overlooked by pediatric health-
care providers.
Ganglioneuromas (GNs) are benign tumors that originate from
neural crest cells, which form the sympathetic nervous system.
They are composed mainly of mature ganglion cells. The Interna-
tional Neuroblastoma Pathology Committee (INPC) deﬁne GNs as a
schwannian stroma-dominant tumor, predominantly composed of
ganglioneuromatous stroma, with a minor component of scattered
collections of differentiating neuroblasts, and/or maturing or
mature ganglion cells [1].BY-NC-ND license (http://
ansky).
Published by Elsevier Inc. All righGNs can either develop de-novo, or as a result of spontaneous or
chemotherapy induced maturation of a less mature neuroblastic
tumor, such as neuroblastoma or ganglioneuroblastoma [2]. GNs
may develop anywhere along the sympathetic nerve chain, most
common locations in descending order of frequency are posterior
mediastinum, retroperitoneum, adrenal gland, neck, and pelvis.
Functional GNs are relatively rare in children.1. Case report
4 year, 2month old, otherwise healthy boy, presented to our care
because of a history of copious sweating of 2 years duration over his
entire body. His mother noted a signiﬁcant increase in the severity
of sweating, over the past 3e4 months, occurring mostly at night.
History was negative for seizures, fever, diarrhea, loose stools,
ﬂushing, chest pain, tremors, abdominal pain, headaches, or visual
changes. On physical exam, no abnormalities were detected. Blood
pressure and heart rate readings, for the last three clinic visits were
reviewed, and were always in the normal range. Initial laboratory
evaluation was unremarkable.
The child was referred to pediatric endocrinology clinic. Thy-
roid function tests and serum electrolytes were all in the normal
range. However, plasma dopamine and norepinephrine levels
were found to be elevated. Urinary normetanephrine to creatinine,ts reserved.
Table 1
Pre-operative and post-operative (48 days after surgery) catecholamine values, in plasma and urine.
Normal range Pre-operative value Post-operative value
Dopamine, plasma (pg/mL) 0e20 724 47
Norepinephrine plasma (pg/mL) 85e1250 3096 499
Metanephrine/Creatinine ratio, urine 0e500 239 191
Normetanephrine/Creatinine ratio, urine 0e610 5043 336
Norepinephrine/Creatinine ratio, urine 27e110 1817 81
Dopamine/Creatinine ratio, urine 220e720 1417 595
Vanilmandelic acid/Creatinine ratio, urine (mg/gCR) 0e13 6 e
Homovanilic acid/Creatinine ratio, urine (mg/gCR) 0e22 11 e
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were also elevated. Table 1 summarizes the pre-operative and
post-operative (48 days after surgery) catecholamine values, in
plasma and urine.
Surgical consultation was obtained and a computerized to-
mography scan of the chest, abdomen and pelvis, with intravenous
and oral contrast, was performed (Fig. 1). The study demonstrated a
pelvic soft tissue mass measuring 3139 51mm. It was rounded,
with some irregular enhancing areas, and multiple speckled calci-
ﬁcations were present, with no evidence of bony erosion, or inva-
sion. The adrenal glands and kidneys appeared normal, with no
evidence of metastatic disease. Metaiodobenzylguanidine (MIBG)Fig. 1. a) Axial contrast enhanced computed tomography of lower pelvis. b) Sagittal
contrast enhanced computed tomography. Presacral soft tissue mass measuring
31  39  51 mm, with irregularly enhancing areas, and multiple speckled
calciﬁcations.scan was done and interestingly showed no uptake in the pelvic
mass.
The child was pretreated with an alpha-blocking agent, Phe-
noxybenzamine 10 mg, given daily orally. The drug was provided
initially as an inpatient and subsequently at home, to complete one
week of treatment prior to surgery. A beta blocking agent, atenolol
1 mg/kg given daily orally, was added for 48 h before surgery. Both
drugs were well tolerated, with no recorded hypotension or
bradycardia. Laparoscopic resection of the pelvic tumor was then
performed. The mass was situated at the aortic bifurcation deriving
most of its blood supply from the sacral artery and branches of the
internal iliac artery. The dissection plane was developed on the
adventitia of the aorta, common iliac arteries and internal iliac ar-
teries. The iliac veins were also intimately associated with themass.
However the adventitial plane remained free of tumor. Normal and
stable vital signs were maintained with tumor manipulation, and
blood pressure support was not required intra-operatively. The
mass was extracted through a slightly enlarged umbilical incision.
After surgery, patient had an uneventful recovery, started a regular
diet on the ﬁrst day after surgery. Pain was well controlled. He
received intravenous morphine for one day (two doses of 0.05 mg/
kg), and oral acetaminophen (15mg/kg every 6 h) for three days. He
was discharged home on the third post-operative day. His symp-
toms of sweating resolved completely after surgery. Pathological
evaluation of the surgical specimen showed maturing ganglio-
neuroma with no evidence of malignancy (Fig. 2). The boy remains
asymptomatic, without evidence of recurrent disease.2. Discussion
Functional adrenergic tumors in general are uncommon in the
pediatric population. Adrenergic tumors presenting with diapho-
resis are reported infrequently, possibly because complaints of
excessive sweating may be difﬁcult to elicit from young children. To
our knowledge, this is the ﬁrst report of a child presenting with
diaphoresis resulting from a functional GN. In another reported
case, a 4month old girl with 3.5 cm right paraspinal neuroblastoma,
who initially presented with an abdominal mass and resting
tachycardia and hypertension, was retrospectively discovered to
have had a history of excessive sweating with feeding [3].
GNs are most commonly clinically silent, and are often discov-
ered incidentally on imaging studies [4]. Because they may not
produce symptoms, GNs may not be discovered until they are very
large and compress nearby structures. In contrast, patients with
GNs that secrete catecholamines or their metabolites may present
with labile hypertension, diarrhea, ﬂushing, diaphoresis, or palpi-
tation [5]. The proportion of patients with GNs, that secrete cate-
cholamines, and are symptomatic, is not known.
Diagnosis may be suspected when excessive levels of cate-
cholamines and their metabolites are detected in serum, or urine
of patients. Axial and functional imaging such as computerized
tomography (CT) scan, magnetic resonance imaging (MRI), and
Fig. 2. a) Low power magniﬁcation. b) High power magniﬁcation. Ganglioneuroma composed of mature ganglion cells deposited in a schwannian stroma.
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raphy are helpful tools for assessment and localization of the tu-
mor [6]. CT images may show a homogenous, low attenuation
mass containing discrete and punctate calciﬁcations in 20% of the
cases. Typically, slight or inhomogeneous enhancement is re-
ported on delayed scans. MRI demonstrates lesions that are rela-
tively homogenous, with low signal intensity on T1 weighted
images, and intermediate to high signal intensity on T2 weighted
images [7]. MIBG may be useful for functional tumors. A retro-
spective analysis of 49 patients with GNs, demonstrated an in-
crease in the catecholamine levels in 39% of the patients, andMIBG
uptake was seen in 57% of the patients [4]. We did not obtain an
MRI, as CT ﬁndings were sufﬁcient to delineate the child’s anat-
omy. Our patient’s tumor was not demonstrated by MIBG scin-
tigraphy despite secreting catecholamines.
Tissue analysis is required for deﬁnitive diagnosis of GNs, since
neither signs, symptoms, nor imaging studies reliably differentiate
benign GNs from malignancies such as neuroblastoma or pheo-
chromocytoma. We feel that percutaneous biopsy is insufﬁcient for
the diagnosis of GNs in childhood, because neuroblastic elements
can be sporadically dispersed within the tumor. A retrospective
review of pathological specimens of 76 GNs in the Italian collabo-
rative study permitted to reclassify one third of them as gan-
glioneuroblastoma intermixed [8]. In addition, malignant
transformation of GN into neuroblastoma, albeit rare, has been
reported in the literature [9,10]. Histological evaluation of resected
specimen is usually sufﬁcient to make the pathological diagnosis.
Immunohistochemistry is used when histological ﬁndings are
indeterminate for GN or mixed with elements of pheochromocy-
toma [11,12].
GNs are not responsive to chemotherapy, and complete surgical
resection is usually curative, with excellent postoperative prognosis
[13]. We feel that surgical resection is required in all patients,
without sacriﬁcing essential structures.
Surgical resection can be challenging however. GNs can be very
large, densely adherent or encase adjacent major vascular struc-
tures. One should aim at complete removal of the tumor. In certain
cases, incomplete resection is an acceptable alternative, given the
good prognosis of these lesions [14]. In a recent Italian co-operative
neuroblastoma group retrospective analysis of 146 children under
18 years old, treated over a 27-year period, surgery was associated
with signiﬁcant risk of complications. Two patients died of bleeding
after surgery, eight developed serious complications, and another
17 suffered moderate, but sometimes permanent complications.
Overall, the surgery-related complication rate was 17.8%. In addi-
tion, three patients underwent nephrectomy in the course of tumor
resection. The authors in this study concluded that cautious surgical
approach should be recommended for childhood GNs [8]. In the
current study we performed the resection laparoscopically.Laparoscopic resection of pelvic and abdominal retroperitoneal
tumors is feasible and can be done safely, evenwhen tumors secrete
catecholamines, with low rate of signiﬁcant blood loss, complica-
tions, and conversion [5].
There are currently no speciﬁc recommendations for preopera-
tive alpha adrenergic blockade for GNs presenting with diaphoresis.
In the Italian co-operative neuroblastoma group study, therewas no
report of any surgery complicated by hypertensive crisis [8]. Unlike
pheochromocytoma, GNs are less likely to be metabolically active.
However, in cases of catecholamines-secreting GNs, there is a po-
tential that excess amounts of catecholamine might be released
during the manipulation of the tumor, such an occurrence can
result in catecholamine surge, leading to intra-operative hemody-
namic instability. We feel that in patients with neurogenic tumors,
which are shown to be catecholamine secreting, preoperative
alpha-adrenergic blockade is necessary and may facilitate safer
surgical excision. Hypertensive spells upon tumor manipulation
have been reported during resection of metabolically active GNs
[15]. We elected to proceed with alpha and beta adrenergic
blockade in our patient. This was well tolerated well and we believe
contributed to a smoother perioperative course.
3. Conclusion
GNs are rare, benign tumors, usually nonfunctional and
asymptomatic, however a proportion of GNs might be hormonally
active. Prolonged and unexplained diaphoresis in a child warrants
screening urine and serum for catecholamine overproduction. The
pre-operative utilization of alpha blockade is not recommended in
non-functional GNs. However in symptomatic, hormonally active
tumors, pre-operative alpha blockade might be indicated and can
be safely performed.
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